Parkinson’s Disease News

The group of 10 other participants and a few onlookers that were gathered around her erupted in laughter. Three years ago, Hamm-Schreiber was diagnosed with Parkinson's disease, a degenerative, ... read more

Patients who undergo deep brain stimulation to treat Parkinson’s disease may lose their ability to swim, even if their motor symptoms improve after the treatment or if they were formerly proficient swimmers, a collection of nine case studies has found. The study, “Beware of deep water after subthalamic deep brain stimulation,” was published in the journal Neurology. “Until more research ... read more

A pilot Phase 2 study evaluating CNM-Au8, an investigational Parkinson’s treatment aiming to protect nerve cells, has started dosing patients, the therapy’s developer, Clene Nanomedicine, announced. The open-label REPAIR-PD (NCT03815916) clinical trial is enrolling up to 24 people, ages 30 to 80 and diagnosed within the past three years, at its one site at the University of Texas Southwestern Medical Center. “We are excited to ... read more

As reported by Apple Insider, the new sensors could help monitor and treat Parkinson's Disease. They would work by monitoring the movements of the wearer and analyzing the data using the Unified ... read more

Dec 06, 2019 (The Expresswire) -- Parkinson's Disease Drugs Market Global Trend, Share and Segmented by Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) ... read more

A new class of dancers, inspired by Tchaikovsky's music from the holiday classic "Nutcracker," are fighting against a serious degenerative neurological condition. (12-5-19) ... read more

Northwestern University and the Parkinson Study Group announced that the Nilotinib in Parkinson's Disease (NILO-PD) study showed that nilotinib, an FDA-approved treatment for chronic myelogenous leukemia being tested for potential repurposing as a Parkinson's drug, was safe and tolerable in its trial population of 76 participants with moderate to advanced Parkinson's but does not exert a clinically meaningful benefit or ... read more

This medical technology firm was working with the Chinese tech giant Tencent on a project to use artificial intelligence to diagnose Parkinson's Disease. This degenerative condition affects something ... read more

Why do we stop dancing when we grow up? Why do we disconnect and alienate ourselves from the body? It is surprising to me that dance/movement therapy (DMT) is not more popular within the fields of psychology and psychotherapy globally. ... read more

Now, a newly released patent also hints that Apple might be looking to expand the Watch’s tracking capabilities to include tremors associated with Parkinson’s Disease. The patent describes using the ... read more

Drug used to treat hallucinations and delusions in Parkinson's shows promise as treatment for dementia-related psychosis (DRP). ... read more

Parkinson's and multisystem atrophy (MSA), both neurodegenerative diseases, are associated with the accumulation of alpha-synuclein proteins in the brain. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the Max Planck Institute for Biophysical Chemistry (MPI-BPC) have investigated the molecular makeup of these protein deposits finding structural diversity. Experts from South Korea, Australia and Argentina were also involved in ... read more

Second-hand smoke may have a neuroprotective effect, as exposure to this type of indoor pollutant seems to be associated with a decreased risk of developing Parkinson’s disease, according to a recent study. Conversely, exposure to certain air pollutants — like nitrogen dioxide and ozone — might contribute to a higher risk of developing the disease. The study, “The impact of ... read more

Northwestern University and the Parkinson Study Group announced that the Nilotinib in Parkinson's Disease (NILO-PD) study showed that nilotinib, an FDA-approved treatment for chronic myelogenous ... read more

In addition, a recent meta-analysis of seven randomized controlled trials comparing the effects of dance therapy to non-dance interventions in Parkinson's disease found that dance was especially ... read more

Parkinson's and multisystem atrophy - both of them neurodegenerative diseases - are associated with the accumulation of alpha-synuclein proteins in the brain. ... read more

A newly unearthed patent reveals that Apple is exploring how a future Apple Watch could help doctors monitor the symptoms of Parkinson's patients. Spotted by AppleInsider, "Passive Tracking of ... read more

More specifically, the Apple Watch app will assist those with Dyskinesia associated with Parkinson's disease. One of the peripherals that Apple highlights that could be used with application is a ... read more

A study found that the drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's and other forms of dementia ... read more

Apple is researching the use of new sensors in the Apple Watch to provide continuous monitoring of dyskinesia and tremors which could help clinicians treat Parkinson's Disease better. Detail from ... read more

Chaperone proteins in human cells dynamically interact with the protein α-Synuclein, which is strongly associated with Parkinson's disease. A disturbed relationship to these "bodyguards" leads to cell damage and the formation of Lewy bodies typical for Parkinson's disease. The findings by researchers from the University of Basel's Biozentrum have been published in Nature. ... read more

A drug approved for hallucinations and delusions associated with Parkinson's disease was shown to be effective in treating patients suffering from dementia-related psychosis (DRP), according to a ... read more

SAN DIEGO -- A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit ... read more

A new University of Toronto study sheds light on how protein strains vary in the brains of those affected by progressive neurodegenerative diseases like Parkinson's, suggesting the need for patient-specific medicines. ... read more

RightEye’s Vision System, an advanced eye-tracking device that measures eye tremors to help diagnose Parkinson’s disease at early stages, has been designated a breakthrough device by the U.S. Food and Drug Administration. This FDA designation is given select medical devices or products that aim to more effectively treat or diagnose ” life-threatening or irreversibly debilitating diseases.” It streamlines processes to speed these devices’ ... read more